Deutsche Bank analyst Justin Bowers raised the firm’s price target on Bio-Techne (TECH) to $72 from $66 and keeps a Buy rating on the shares. The firm cites accretion prospects of Bio-Techne’s acquisition of Wilson Wolf for the target increase.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TECH:
- Bio-Techne announces collaboration with Wyss Center for Bio and Neuroengineering
- Bio-Techne price target raised to $68 from $65 at Argus
- Bio-Techne announces licensing agreement with Monod Bio
- Bio-Techne price target lowered to $68 from $72 at Evercore ISI
- Bio-Techne price target raised to $70 from $65 at UBS